People: Akorn Inc (AKRX.O)

AKRX.O on Nasdaq

1:01pm EST
Change (% chg)

$0.64 (+1.92%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Kapoor, John 

Dr. John N. Kapoor, Ph.D. serves as Chairman of the Board of Akorn Inc. Dr. Kapoor served as interim Chief Executive Officer from March 2001 to May 2002 and as Chief Executive Officer from May 2002 to December 2002. Dr. Kapoor is the President of EJ Financial Enterprises, Inc. (a health care consulting and investment company). Dr. Kapoor is the chairman of the board of directors of Insys Therapeutics, a private drug development company focused on pain and oncology, into which NeoPharm, Inc. (previously a publicly held biopharmaceutical company) merged in October 2010. Prior to NeoPharm’s merger, Dr. Kapoor was the chairman of its board of directors.

Basic Compensation

Total Annual Compensation, USD 2,083
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 2,083

Options Compensation

  Quantity Market Value
Exercisable 385,000 --
Unexercisable 125,000 --
Exercised 5,000 20,475.00
Name Fiscal Year Total

John Kapoor


Rajat Rai


Duane Portwood


Bruce Kutinsky


Steven Joseph Lichter


Mark Silverberg

As Of  30 Dec 2014
Search Stocks